“The clinical use of neurotrophic factors is difficult due to side effects and elevated costs, but other molecules might be effective and more easily obtained. Among them, some are derived from Cannabis sativa.
Cannabidiol (CBD) is the major non-psychotropic component found on the surface of such plant leaves.
The present study aimed to investigate the neuroprotective potential of CBD…
The present results show that CBD possesses neuroprotective characteristics that may, in turn, be promising for future clinical use.”